Skip to main content
. 2016 Mar 15;6(4):806–818.

Figure 6.

Figure 6

M2698 reduced tumor burden and prolonged survival in the U251 human glioblastoma xenograft mouse model. Mice bearing U251 orthotopic tumors were treated with vehicle (n=9) or M2698 25 mg/kg qd po (n=10) from Day 18 (when mean tumor mass was 6 mg) until Day 50 (end of study). A. MRI was performed on Days 17 and 31. Representative images are shown. B. Group survival curves of tumor-bearing animals treated with vehicle or M2698 25 mg/kg. qd po. po, oral administration; qd, once daily.